Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Hansa eyes US listing ahead of FDA verdict on Idefirix
With the FDA expected to decide on its kidney transplant drug before year-end, Hansa Biopharma is mulling its stock listing options in the U.S.
Fraiser Kansteiner
Aug 24, 2026 2:45pm
RFK Jr. joins Trump in renewed push on vaccine recommendations
Aug 24, 2026 11:30am
When is the new who in HCP marketing
Brought to you by
Phreesia Network Solutions
Regulatory tracker: GSK, Gilead, Takeda and more
Aug 24, 2026 11:05am
Designing an agentic, future‑ready tech roadmap for emerging pharma
Brought to you by
ZS
Cellares eyes company resizing after large customer walks away
Aug 24, 2026 10:25am
